Creating the framework for collaborative and innovative patient-centred pharmacy practice
Pharmacy Directory Pharmacist Directory Pharmacist Profile Directory Pharmacy Technician Directory Professional Development Pharmacy Technicians Friday Five & Newsletter Manitoba Prescribing Practices Program (M3P) Applications Orientation to Expanded Scope Member Login
|April 22, 2016
The Friday Five and Spring 2016 Newsletter is now available.
March 16, 2016
The College's 2015 Annual Report and Financial Statements are now available.
Registry Checks Deadline
Adult Abuse Registry and Child Abuse Registry checks are due June 1, 2016. For more information please see Pharmacists Currently Registered and Licenced.
For archived posts, please see News & Events.
For more information on previously issued Health Canada Advisories, Warnings and Recalls and to subscribe, go to MedEffect Canada at http://www.hc-sc.gc.ca/dhp-mps/medeff/index_e.html
MedEffect Canada - Health Product InfoWatch
Content: Monthly Recap
Content: Monthly Recap; Review article: Review article: Melatonin and neurologic adverse reactions in children and adolescents
Content: Monthly Recap; Review article: Pseudoephedrine and ischemic colitis; Product confusion alert: Risk of eye injury with improper use of hydrogen peroxide-based contact lens solutions; Vaccine safety review: Report for April 1, 2015 to June 30, 2015; Product Monograph Update: Piperacillin/Tazobactam for Injection and Piperacillin for Injection
Content: Monthly Recap; Product Monograph Update: Galexos (simeprevir); Product Monograph Update: Optiray (loversol)
Content: Monthly Recap; Review article: Finasteride and suicidality
Content: Monthly Recap; Case report; Product confusion alert: Health product name confusion; Vaccine safety review; Product monograph and instructions for use updates
Content: Monthly recap; Safety Brief: Brilinta (ticagrelor) safety reminders
Content: Case Report: Negative Pressure Wound Therapy devices and the risk of bleeding; Product monograph update: Malarone (atovaquone and proguanil); Product monograph update: PDE5 inhibitors (sildenafil, tadalafil, vardenafil)
Content: Monthly recap; New information; Review article: Rivaroxaban and liver injury
Content: Monthly recap
Content: Monthly recap
Content: Monthly recap; New information; Review article: Febuxostat and international reports of agranulocytosis and drug rash with eosinophilia and systemic symptoms (DRESS); Product monograph update: Nexavar (sorafenib)